文献速递神经肌肉病脑血管病

理解遗传性视神经病的分子基础与发病机制:朝向改进诊断与管理

Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management.
PubMed 文献 · Lancet Neurol · 2022-09-22

遗传性视神经病由核基因组和线粒体基因组缺陷引起,主要表型为显性视神经萎缩和Leber遗传性视神经病。现代分子诊断扩展了对影响视神经的遗传病的基因型与表型认识,线粒体功能障碍是这些疾病病理生理的统一特征,针对病因的治疗正在进入临床试验。

要点

  • 遗传性视神经病由核基因组和线粒体基因组缺陷引起。
  • 主要表型为显性视神经萎缩和Leber遗传性视神经病。
  • 线粒体功能障碍是病理生理的统一特征,视网膜神经节细胞及其轴突易受损。

核心结论

  • 遗传性视神经病由核基因组和线粒体基因组缺陷引起,主要表型为显性视神经萎缩和Leber遗传性视神经病。
  • 线粒体功能障碍似乎是这些疾病病理生理的统一特征,提示视网膜神经节细胞及其轴突对线粒体稳态扰动尤其敏感。
  • 随着对遗传病发病机制的理解加深,针对病因的治疗正在涌现并进入临床试验。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 现代分子诊断的进步扩展了对影响视神经的遗传病基因型与表型的认识,这些疾病可单独或合并各种形式的神经与系统变性。
  • 针对病因的治疗包括旨在阻止神经变性级联、替换或编辑缺陷基因或其蛋白产物、潜在再生受损视神经以及防止代际疾病传播的治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hereditary optic neuropathies result from defects in the human genome, both nuclear and mitochondrial. The two main and most recognised phenotypes are dominant optic atrophy and Leber hereditary optic neuropathy. Advances in modern molecular diagnosis have expanded our knowledge of genotypes and phenotypes of inherited disorders that affect the optic nerve, either alone or in combination, with various forms of neurological and systemic degeneration. A unifying feature in the pathophysiology of these disorders appears to involve mitochondrial dysfunction, suggesting that the retinal ganglion cells and their axons are especially susceptible to perturbations in mitochondrial homoeostasis. As we better understand the pathogenesis behind these genetic diseases, aetiologically targeted therapies are emerging and entering into clinical trials, including treatments aimed at halting the cascade of neurodegeneration, replacing or editing the defective genes or their protein products, and potentially regenerating damaged optic nerves, as well as preventing generational disease transmission.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Newman NJ, Yu-Wai-Man P, Biousse V, et al. Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management. Lancet Neurol. 2022. PMID: 36155660. doi:10.1016/S1474-4422(22)00174-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。